Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
In Candida albicans , the ERG11 gene encodes lanosterol demethylase, the target of the azole antifungals. Mutations in ERG11 that result in an amino acid substitution alter the abilities of the azoles to bind to and inhibit Erg11, resulting in resistance. Although ERG11 mutations have been observed in clinical isolates, the specific contributions of individual ERG11 mutations to azole resistance in C. albicans have not been widely explored. We sequenced ERG11 in 63 fluconazole (FLC)-resistant clinical isolates. Fifty-five isolates carried at least one mutation in ERG11 , and we observed 26 distinct positions in which amino acid substitutions occurred. We mapped the 26 distinct variant positions in these alleles to four regions in the predicted structure for Erg11, including its predicted catalytic site, extended fungus-specific external loop, proximal surface, and proximal surface-to-heme region. In total, 31 distinct ERG11 alleles were recovered, with 10 ERG11 alleles containing a single amino acid substitution. We then characterized 19 distinct ERG11 alleles by introducing them into the wild-type azole-susceptible C. albicans SC5314 strain and testing them for susceptibilities to FLC, itraconazole (ITC), and voriconazole (VRC). The strains that were homozygous for the single amino acid substitutions Y132F, K143R, F145L, S405F, D446E, G448E, F449V, G450E, and G464S had a ≥4-fold increase in FLC MIC. The strains that were homozygous for several double amino acid substitutions had decreased azole susceptibilities beyond those conferred by any single amino acid substitution. These findings indicate that mutations in ERG11 are prevalent among azole-resistant clinical isolates and that most mutations result in appreciable changes in FLC and VRC susceptibilities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, in Candida auris, ERG11 polymorphisms as well as an increased number of ERG11 gene copies are thought to be responsible for its largely intrinsic azole resistance37–40”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [38]
In the citing paper
“Aneuploidy can alter fluconazole tolerance in C. albicans drug38,51.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [38]
In the citing paper
“Aneuploidy and/or loss of heteroresistance are rapidly acquired genome changes that can result in increased tolerance. and are likely to affect one or several genes that alter tolerance level.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [38]
In the citing paper
“Frequently reported in association with triazole resistance in both yeast and molds, mutations in sterol-demethylase have been observed to have variable and agent specific effects on the MICs of triazole antifungals, potentially as a result of agent-specific stabilizing interactions with sterol-demethylase residues (4, 5).”
From Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance (2021) · cites this paper as [5]
In the citing paper
“In both Candida albicans and Aspergillus fumigatus, the mutation encoding a tyrosine to phenylalanine amino acid substitution at a specific residue localized to the sterol-demethylase catalytic domain (Y132F in C. albicans CaERG11 and Y121F in A. fumigatus Afcyp51A) confers increased resistance to all triazoles except for posaconazole (4–7).”
From Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance (2021) · cites this paper as [5]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Amino acid substitution matrices from protein blocks.
Henikoff, S., & Henikoff, J. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10915 · Cited by 6,218
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<490::aid-jcc1>3.0.co;2-p · Cited by 5,306
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
The SAT1 flipper, an optimized tool for gene disruption in Candida albicans
Reuß, O., Vik, Å., Kolter, R., & Morschhäuser, J. (2004) · Gene · doi:10.1016/j.gene.2004.06.021 · Cited by 742
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Cytochrome P450 and the Individuality of Species
Nelson, D. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1352 · Cited by 591
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Sanglard, D., Ischer, F., Koymans, L., & Bille, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465
Resistance Mechanisms in Clinical Isolates of Candida albicans
White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461
Research works printed but not linked: 1
- Sanglard D, Bille J. 2002. Action of and resistance to antifungal agents, p 370. In Calderone RA (ed), Candida and candidiasis. American Society for Microbiology, Washington, DC.
Cited by
Items 101–200 of 336
Du, M., Hu, W., Tamura, T., Alshahni, M. M., Satoh, K., Yamanishi, C., Naito, T., & Makimura, K. (2021) · Mycopathologia · doi:10.1007/s11046-020-00526-w · Cited by 28
Insights into the Multi-Azole Resistance Profile in Candida haemulonii Species Complex
Silva, L. N., Ramos, L. S., de Oliveira, S. S. C., Magalhães, L. B., Squizani, E. D., Kmetzsch, L., Vainstein, M. H., Branquinha, M. H., & dos Santos, A. L. S. (2020) · Journal of Fungi · doi:10.3390/jof6040215 · Cited by 27
Sitterlé, E., Coste, A. T., Obadia, T., Maufrais, C., Chauvel, M., Sertour, N., Sanglard, D., Puel, A., d’Enfert, C., & Bougnoux, M. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz537 · Cited by 27
Wu, Y., Gao, N., Li, C., Gao, J. Q., & Ying, C. (2017) · FEMS Yeast Research · doi:10.1093/femsyr/fox012 · Cited by 27
Gisi, U. (2021) · Plant Pathology · doi:10.1111/ppa.13429 · Cited by 26
Gong, J., Chen, X.-F., Fan, X., Xu, J., Zhang, H., Li, R., Chen, S. C. ‐., Kong, F., Zhang, S., Sun, Z., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03807-22 · Cited by 26
The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
Zobi, C., & Algül, Ö. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70045 · Cited by 26
Nishimoto, A. T., Zhang, Q., Hazlett, B., Morschhäuser, J., & Rogers, P. D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00078-19 · Cited by 24
Self-citationKeighley, C., Gall, M. L., van Hal, S. J., Halliday, C. L., Chai, L. Y. A., Chew, K. L., Biswas, C., Slavin, M. A., Meyer, W., Sintchenko, V., et al. (2022) · Journal of Fungi · doi:10.3390/jof8090896 · Cited by 25
Demin, K. A., Refeld, A. G., Bogdanova, A. A., Prazdnova, E. V., Popov, I. V., Kutsevalova, O. Y., Ermakov, A. M., Bren, A. B., Rudoy, D. V., Chistyakov, V. A., et al. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09776-6 · Cited by 25
Bergin, S. A., Doorley, L. A., Rybak, J. M., Wolfe, K. H., Butler, G., Cuomo, C. A., & Rogers, P. D. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01619-23 · Cited by 24
Self-citationKumar, A., Nair, R., Kumar, M., Banerjee, A., Chakrabarti, A., Rudramurthy, S. M., Bagga, R., Gaur, N. A., Mondal, A. K., & Prasad, R. (2020) · Folia Microbiologica · doi:10.1007/s12223-020-00785-6 · Cited by 24
Shrivastava, M., Kouyoumdjian, G. S., Kirbizakis, E., Ruiz, D., Henry, M., Vincent, A. T., Sellam, A., & Whiteway, M. S. (2023) · mBio · doi:10.1128/mbio.01807-23 · Cited by 24
Suchodolski, J., Derkacz, D., Bernat, P., & Krasowska, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-86012-9 · Cited by 24
Kuan, C. S., Cham, C. Y., Singh, G., Yew, S. M., Tan, Y.-C., Chong, P.-S., Toh, Y. F., Atiya, N., Na, S. L., Lee, K. W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161008 · Cited by 24
Brettner, L. M., Ho, W.-C., Schmidlin, K., Apodaca, S., Eder, R., & Geiler‐Samerotte, K. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101951 · Cited by 23
Sathi, F. A., Paul, S. K., Ahmed, S., Alam, M. M., Nasreen, S. A., Haque, N., Islam, A., Nila, S. S., Afrin, S. Z., Aung, M. S., et al. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7090211 · Cited by 23
Zande, P. V., Gautier, C., Kawar, N., Maufrais, C., Metzner, K., Wash, E., Beach, A. K., Bracken, R., Maciel, E. I., de Sá, N. P., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012497 · Cited by 23
Liu, Z., Yang, H., Huang, R., Li, X., Sun, T., & Zhu, L. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00284-24 · Cited by 23
Siswina, T., Miranti, M., Sumiarsa, D., Apriyanti, E., Dohi, H., & Kurnia, D. (2023) · Molecules · doi:10.3390/molecules28237705 · Cited by 22
Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
Chambial, P., Thakur, N., Bhukya, P. L., Anbazhagan, S., & Kumar, U. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04262-x · Cited by 22
Azole sensitivity in Leptosphaeria pathogens of oilseed rape: the role of lanosterol 14α-demethylase
Sewell, T. R., Hawkins, N. J., Stotz, H. U., Huang, Y., Kelly, S. L., Kelly, D. E., FRAAIJE, B. A., & Fitt, B. D. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-15545-9 · Cited by 22
Kodavati, M. M., Peroumal, D., & Acharya, N. (2018) · Molecular Microbiology · doi:10.1111/mmi.14004 · Cited by 22
Hassanpour, P., Hamishehkar, H., Baroughi, B. B., Baradaran, B., Shotorbani, S. S., Mohammadi, M., Shomali, N., Maleki, L. A., & Nami, S. (2021) · Assay and Drug Development Technologies · doi:10.1089/adt.2020.1057 · Cited by 22
Siswina, T., Rustama, M. M., Sumiarsa, D., & Kurnia, D. (2023) · F1000Research · doi:10.12688/f1000research.125645.3 · Cited by 21
Wu, Y., Li, C., Wang, Z., Gao, J., Tang, Z., Chen, H., & Ying, C. (2018) · Medical Mycology · doi:10.1093/mmy/myx099 · Cited by 19
Dižová, S., Černáková, L., & Bujdáková, H. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0574-z · Cited by 21
Espinel‐Ingroff, A., Sasso, M., Turnidge, J. D., Arendrup, M. C., Botterel, F., Bourgeois, N., Bouteille, B., Cantón, R., Cassaing, S., Dannaoui, É., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01093-21 · Cited by 21
Hamdy, R., Hamoda, A. M., Al-Khalifa, M., Menon, V., El‐Awady, R., & Soliman, S. S. M. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00196a · Cited by 20
Toepfer, S., Lackner, M., Keniya, M. V., & Monk, B. C. (2023) · Journal of Fungi · doi:10.3390/jof9020168 · Cited by 20
Zhou, X., Hilk, A. L., Solis, N. V., de Sá, N. P., Hogan, B. M., Bierbaum, T. A., Poeta, M. D., Filler, S. G., Burrack, L. S., & Selmecki, A. M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012389 · Cited by 20
An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required for Candida albicans virulence
Villasmil, M. L., Barbosa, A. D., Cunningham, J. L., Siniossoglou, S., & Nickels, J. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235746 · Cited by 20
Espinel‐Ingroff, A. (2022) · Journal of Fungi · doi:10.3390/jof8030309 · Cited by 20
Lim, H. J., Shin, J. H., Kim, M., Yong, D., Byun, S. A., Choi, M. J., Lee, S. Y., Won, E. J., Kee, S., Kim, S. H., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00740-20 · Cited by 20
Erratum: Candida auris: The recent emergence of a multidrug-resistant fungal Pathogen
Forsberg, K., Woodworth, K. R., Walters, M., Berkow, E. L., Jackson, B. R., Chiller, T. M., & Vallabhaneni, S. (2019) · Medical Mycology · doi:10.1093/mmy/myy156 · Cited by 20
Cha, H., Won, D., & Bahn, Y.-S. (2025) · mBio · doi:10.1128/mbio.02475-23 · Cited by 19
“In other fungal species, azole resistance is primarily linked to mutations in the ERG11 gene, which encodes lanosterol demethylase, the target of azole drugs (67, 68).”
ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis
Díaz, L., Castellá, G., Bragulat, M. R., & Cabañes, F. J. (2022) · Mycopathologia · doi:10.1007/s11046-022-00696-9 · Cited by 19
Binder, U., Arastehfar, A. A., Schnegg, L., Hörtnagl, C., Polat, S. H., Perlin, D. S., & Lass‐Flörl, C. (2020) · Journal of Fungi · doi:10.3390/jof6040377 · Cited by 19
Escribano, P., Marcos-Zambrano, L. J., Gómez, A., Sánchez, C., Martínez‐Jiménez, M. D. C., Bouza, E., & Guinea, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00400-17 · Cited by 19
Derkacz, D., & Krasowska, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043966 · Cited by 18
Molecular characterization of some multidrug resistant Candida Auris in egypt
Ahmed, S. H., El-Kholy, I. M. A., El-Mehalawy, A. A., Mahmoud, E. M., & Elkady, N. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-88656-3 · Cited by 18
Wang, X., Liu, J., Chen, J., Zhang, M., Tian, C., Peng, X.-P., Li, G., Chang, W., & Lou, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104771 · Cited by 18
Vandecruys, P., Baldewijns, S., Sillen, M., Genechten, W. V., & Dijck, P. V. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2233696 · Cited by 18
Ning, Y., Sun, T., Dai, R., Luo, Z.-Y., Yu, S.-Y., Zhang, G., Mei, Y., Lin, Y., Hasi, C., Chen, S. C.-A., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad356 · Cited by 17
Chew, K. L., Cheng, J. W. S., Jureen, R., Lin, R. T. P., & Teo, J. W. P. (2017) · Mycoscience · doi:10.1016/j.myc.2016.11.001 · Cited by 17
Rodrigues, L. S., Gazara, R. K., Passarelli‐Araujo, H., Valengo, A. E., Pontes, P. V. M., da Fonseca, R. N., de Souza, R. F., Venâncio, T. M., & Dalla-Costa, L. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01535 · Cited by 17
Urbanek, A. K., Łapińska, Z., Derkacz, D., & Krasowska, A. (2022) · Pathogens · doi:10.3390/pathogens11111289 · Cited by 16
Elgammal, Y., Salama, E. A., & Seleem, M. N. (2023) · Medical Mycology · doi:10.1093/mmy/myad081 · Cited by 16
Prakash, S. M. U., Nazeer, Y., Jayanthi, S., & Kabir, M. A. (2020) · PubMed Central · doi:10.22099/mbrc.2020.36298.1476 · Cited by 15
Yang, Q., He, B., Chen, C., Wang, H., Li, W., Xue, X., Qiu, T., Hao, X., Lv, F., & Wang, S. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00393 · Cited by 15
Chen, Z., Luo, T., Huang, F., Yang, F., Luo, W., Chen, G., Cao, M., Wang, F., & Zhang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.816290 · Cited by 15
Lotfali, E., Erami, M., Fattahi, A., Nemati, H., Ghasemi, Z., & Mahdavi, E. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.2.10326 · Cited by 14
Candida auris Resistance Mechanisms to Amphotericin B Alternative Treatments Development
Fenton, A., & John, G. K. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-024-00233-w · Cited by 14
Benedetti, V. P., Savi, D. C., Aluízio, R., Adamóski, D., Kava, V. M., Galli-Terasawa, L. V., & Glienke, C. (2019) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0473-2018 · Cited by 14
Chew, K. L., Octavia, S., Jureen, R., Lin, R. T. P., & Teo, J. W. P. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13516 · Cited by 13
Spruijtenburg, B., Meijer, E. F. J., Xiao, M., Shawky, S. M., Meis, J. F. G. M., de Groot, T., & El‐Kholy, M. A. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.06.012 · Cited by 13
Antifungal activity of Cinnamaldehyde derivatives against fluconazole-resistant Candida albicans
Long, Y., Xu, J., Hu, Z., Fan, X., & Wang, H. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106877 · Cited by 13
Cheng, J.-W., Liao, K., Kudinha, T., Yu, S.-Y., Xiao, M., Wang, H., Kong, F., & Xu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01106-7 · Cited by 13
Kordalewska, M., Guerrero, K. D., Garcia‐Rubio, R., Jiménez‐Ortigosa, C., Mediavilla, J. R., Cunningham, M. H., Hollis, F., Hong, T., Chow, K. F., Kreiswirth, B. N., et al. (2021) · Journal of Fungi · doi:10.3390/jof7070552 · Cited by 13
Lu, Y., Zhou, Z., Mo, L., Guo, Q., Peng, X., Hu, T., Zhou, X., Ren, B., & Xu, X. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09960-3 · Cited by 13
Graham, D. O., Wilson, R. K., Ruma, Y. N., Keniya, M. V., Tyndall, J. D. A., & Monk, B. C. (2021) · Journal of Fungi · doi:10.3390/jof7110897 · Cited by 12
Sun, H., Cai, X., Yan, B., Bai, H., Meng, D., Mo, X., He, S., Su, G., & Jiang, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.798535 · Cited by 12
Siswina, T., Rustama, M. M., Sumiarsa, D., & Kurnia, D. (2022) · F1000Research · doi:10.12688/f1000research.125645.1 · Cited by 12
Daneshnia, F., Polat, S. H., İlkit, M., Shor, E., de Almeida, J. N., Favarello, L. M., Colombo, A. L., Arastehfar, A. A., & Perlin, D. S. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.906681 · Cited by 12
Accoceberry, I., Rougeron, A., Biteau, N., Chevrel, P., Fitton‐Ouhabi, V., & Noël, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01483-17 · Cited by 12
Wang, X., Zhong, H., Ma, S.-S., Huang, Y., Xu, W., & Wang, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155948 · Cited by 11
Zeitoun, H., Salem, R. A., Guink, N. E., Tolba, N. S., & Mohamed, N. M. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03512-0 · Cited by 11
Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris
Toepfer, S., Lackner, M., Keniya, M. V., Zenz, L.-M., Friemert, M., Bracher, F., & Monk, B. C. (2023) · Journal of Fungi · doi:10.3390/jof9060663 · Cited by 11
Panapruksachat, S., Iwatani, S., Oura, T., Vanittanakom, N., Chindamporn, A., Niimi, K., Niimi, M., Lamping, E., Cannon, R. D., & Kajiwara, S. (2016) · Medical Mycology · doi:10.1093/mmy/myv117 · Cited by 11
Deciphering the multidrug resistance paradigm in Candida auris
Santana, D. J., Cauldron, N. C., Rogers, P. D., & Cuomo, C. A. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01062-24 · Cited by 10
Self-citationAntifungal screening and in silico mechanistic studies of an in‐house azole library
Sarı, S., Kart, D., Sabuncuoğlu, S., Doğan, İ. S., Özdemir, Z., Merde, İ. B., Gencel, M., Essiz, S. G., Reynisson, J., Karakurt, A., et al. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13587 · Cited by 10
Gelain, J., Zhao, B., Price, S. G. A., Kaur, H., Blank, A., Zhezheng, Z., Luo, C., & Schnabel, G. (2024) · Plant Disease · doi:10.1094/pdis-09-24-1962-re · Cited by 9
Kuan, C. S., Ng, K. P., Yew, S. M., Meleh, H. U., Seow, H. F., How, K. N., Yeo, S. K., Jee, J. M., Tan, Y.-C., Yee, W.-Y., et al. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-01032-z · Cited by 9
Human Oropharyngeal Candidiasis: From Etiology to Current Treatment
Qadir, M. I., Bashir, H., & Ahmad, M. H. (2023) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023049730 · Cited by 8
Gawad, M. M. A. E., & Shady, R. M. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10405-4 · Cited by 8
Tsybruk, T. V., Kaluzhskiy, L. A., Mezentsev, Y. V., Makarieva, T. N., Tabakmakher, K. M., Ivanchina, N. V., Dmitrenok, P. S., Baranovsky, A. V., Gilep, A. A., & Ivanov, A. S. (2023) · Biomedicines · doi:10.3390/biomedicines11112873 · Cited by 8
Involvement of mitochondrial respiratory chains in virulence factors of Candida albicans
Hassan, R. Y. A., Ali, M. M., Cui, S., & Bilitewski, U. (2025) · Fungal Biology Reviews · doi:10.1016/j.fbr.2025.100448 · Cited by 8
Harrison, M., Rinker, D. C., LaBella, A. L., Opulente, D. A., Wolters, J. F., Zhou, X., Shen, X., Groenewald, M., Hittinger, C. T., & Rokas, A. (2026) · PLoS Genetics · doi:10.1371/journal.pgen.1012091 · Cited by 8
Tan, X., Baugh, K., Bulman, Z. P., & Wenzler, E. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00388-1 · Cited by 8
Mohamed, A., Mohamed, M. S., Hussain, M. A., & Ahmed, I. F. (2020) · F1000Research · doi:10.12688/f1000research.24854.2 · Cited by 8
Son, Y.-E., Arques, C. P., & Heitman, J. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003598 · Cited by 7
Liu, C., Yao, X., Liu, C., You, S., Qi, W. D., & Wang, M. (2023) · Analytical Methods · doi:10.1039/d3ay00259d · Cited by 7
Álvarez‐Pérez, S., Quevedo‐Caraballo, S., García, M. E., & Blanco, J. L. (2024) · Medical Mycology · doi:10.1093/mmy/myae053 · Cited by 7
Edwin, M. A., Velmurugan, R., & Patel, S. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01836-w · Cited by 7
A study on Vulvovaginal candidiasis among non-pregnant women
Kavitha, Y., Karuppayil, S. M., Anandi, V., & Babu, H. (2018) · Tropical Journal of Pathology and Microbiology · doi:10.17511/jopm.2018.i05.05 · Cited by 7
Hatami, F., Manifar, S., Asghari-Paskiabi, F., Amiri, F. B., Nojoumi, S. A., & Jahanshiri, Z. (2023) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2023.105757 · Cited by 7
Mechanisms of antifungal resistance
Delgado, J., Núñez, F., Bermúdez, E., & Asensio, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00156-8 · Cited by 7
Saeed, N. K., Almusawi, S., & Al‐Beltagi, M. (2024) · World Journal of Virology · doi:10.5501/wjv.v13.i4.98839 · Cited by 6
Valente, M. R., Alcântara, L. M., Cintra, D. S., Mendoza, S. R., Medeiros, E. G., Gomes, K. X., Honorato, L., Almeida, M. D. A., Vieira, C. B., Nosanchuk, J. D., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01746-24 · Cited by 6
An Update on the Recent Emergence of Candida auris
Jain, M., Jain, A., Khare, B., Jain, D. K., Khan, R., & Jain, D. (2022) · Asian Journal of Dental and Health Sciences · doi:10.22270/ajdhs.v2i1.11 · Cited by 6
Fluconazole-induced changes in azole resistance and biofilm production in Candida glabrata in vitro
Xia, C., Liu, R., Zhang, S., Shen, J., & Wang, Z. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116683 · Cited by 7
Konings, M., van den Ende, B. G., Raats, M. W. J., Fahal, A. H., van de Sande, W. W. J., & Hagen, F. (2024) · Mycopathologia · doi:10.1007/s11046-023-00807-0 · Cited by 6
Dąbrowska, M., Zielińska‐Bliźniewska, H., Kwiatkowski, P. A., Guenther, S., Łopusiewicz, Ł., Kochan, E., Pruss, A., & Sienkiewicz, M. (2023) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/157995 · Cited by 6
Alsulaimany, M., Binjubair, F. A., Tatar, E., Kelly, D. E., Kelly, S. L., Warrilow, A. G. S., Keniya, M. V., Monk, B. C., Parker, J. E., & Simons, C. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00863d · Cited by 5
Induction of Antifungal Tolerance Reveals Genetic and Phenotypic Changes in Candida glabrata
Chedraoui, C., Fattouh, N., Hachem, S. E., Younes, M., & Khalaf, R. A. (2025) · Journal of Fungi · doi:10.3390/jof11040284 · Cited by 5
Zhu, W., & Guo, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1811011 · Cited by 5
Derkacz, D., Grzybowska, M., Cebula, L., & Krasowska, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417499 · Cited by 5
Trichosporon and Antifungal Resistance: Current Knowledge and Gaps
Miranda, I. L., Peres, N. T. A., Bastos, R. W., Rossato, L. L., Morio, F., & Santos, D. A. (2025) · Mycopathologia · doi:10.1007/s11046-025-00969-z · Cited by 5
Advances in Genomics of Human Fungal Pathogens
Kollath, D. R., Teixeira, M. D. M., & Barker, B. M. (2018) · Population genomics · doi:10.1007/13836_2018_41 · Cited by 5
Singh, G. (2022) · Current Drug Discovery Technologies · doi:10.2174/1570163819666220615142933 · Cited by 5
Metadata
- Authors
- Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D.
- Affiliations
- University of Tennessee Health Science Center (US)
- University of Illinois Urbana-Champaign (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2015-01
- Volume
- 59
- Issue
- 1
- Pages
- 450-460
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC4291385
- OpenAlex
- W2151649073
- Cited by
- 294
- References
- 46
- Citations by year
- 2026: 25 · 2025: 33 · 2024: 31 · 2023: 39 · 2022: 31 · 2021: 29 · 2020: 33 · 2019: 26 · 2018: 15 · 2017: 17 · 2016: 8 · 2015: 7
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI058145)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, ERG11, azole resistance, fluconazole resistance, itraconazole, voriconazole, amino acid substitutions, clinical isolates, double mutations, antifungal susceptibility, drug target mutations
- MeSH terms
- Antifungal Agents, Azoles, Candida albicans, Candidiasis, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Fluconazole, Itraconazole, Amino Acid Substitution, Catalytic Domain, Drug Resistance, Fungal, Sterol 14-Demethylase, 14-alpha Demethylase Inhibitors, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.